3
Announcements
Trials
Browse
Landscape
Status
Recruiting
4
Active not recruiting
3
Terminated
1
Not yet recruiting
1
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
70
Cyclophosphamide
46
Cisplatin
42
Nivolumab
33
Radiotherapy
30
Paclitaxel
30
Gemcitabine
30
Carboplatin
28
Docetaxel
26
Dexamethasone
22
atezolizumab
20
Blood Specimen Collection
20
Bevacizumab
19
Rituximab
18
Radiosurgery
18
Fluorouracil
18
fludarabine
17
Magnetic Resonance Spectroscopy
17
Leucovorin
17
Lenalidomide
17
Surveys and Questionnaires
16
Oxaliplatin
16
Doxorubicin
15
Irinotecan
14
Etoposide
14
palbociclib
13
Vincristine
13
Radiotherapy, Intensity-Modulated
13
Prednisone
13
Letrozole
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonoscopy
×
90 days
×
Clear all
NCT07502469
2026-03-31
BENEFIT
Elsan
Completed
341 enrolled